Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab.

PLoS One · 2020 · PMC7384624 · PMID 32716916

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Absolute counts of double negative B cells were significantly decreased while memory B cells also showed a trend towards reduced numbers.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

NAT treated MS patients displayed elevated total B cell and memory B cell counts but these effects did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.